ReviewJournal of hematology & oncology2022
ASXL1/2 mutations and myeloid malignancies.
Edward A Medina et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
36 papers cite it
this paperpooled itcites it
ReviewJournal of hematology & oncology2022
Edward A Medina et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.